Logo Image
Opinion|Videos|November 27, 2024

Patient Selection and Personalized Treatment Strategies

Key Takeaways

  • Transitioning from IV to oral medications requires careful management of adherence, side effects, and therapeutic efficacy to ensure optimal patient outcomes.
  • Patient-specific factors, such as comorbidities and drug interactions, are critical in optimizing treatment during the transition from IV to oral medications.
SHOW MORE

An overview of challenges in transitioning from IV to oral medications and guidance on identifying NSCLC patient populations most likely to benefit from HER2-directed therapies through informed patient selection strategies.

Episodes in this series

Video content above is prompted by the following:

  • What challenges may exist when transitioning from IV to oral medications?
  • Which NSCLC patient populations are most likely to benefit from HER2-directed therapies and how should clinicians approach patient selection?

Related Content